Human medicines European public assessment report (EPAR): Myclausen, mycophenolate mofetil, Date of authorisation: 07/10/2010, Revision: 17, Status: Authorised
Download medicine data
Human medicines European public assessment report (EPAR): Sorafenib Accord, sorafenib, Date of authorisation: 09/11/2022, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Kayshild, semaglutide, Date of authorisation: 26/03/2026, Status: Authorised
Human medicines European public assessment report (EPAR): Fylrevy, estetrol, Date of authorisation: 26/03/2026, Status: Authorised
Union Product Database
We are delighted to announce that the 25th edition of the European Congress of Internal Medicine (ECIM 2027) will take place in Paris from 31 March to 3 April 2027.
Join us at the iconic Cité des sciences et de l'industrie for an enriching and engaging scientific experience. The congress will feature a comprehensive programme including scientific sessions, keynote lectures, interactive workshops, clinical case discussions, and poster presentations.
Human medicines European public assessment report (EPAR): Copiktra, duvelisib, Date of authorisation: 19/05/2021, Revision: 3, Status: Withdrawn
Core summary of product characteristics for human normal immunoglobulin for subcutaneous and intramuscular use - Scientific guideline
Clinical investigation of human normal immunoglobulin for subcutaneous and/or intramuscular administration (SCIg/IMIg) - Scientific guideline